Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Privi Speciality Chemicals has made available the audio recording of its analyst and investor call. The call, held on May 12, 2026, discussed the company's audited standalone and consolidated financial results for Q4 and the full year ended March 31, 2026. This allows investors to review the discussions.
May 12 2026 18:05:00
Privi Speciality Chemicals Ltd - 530117 - Corporate Action - Record Date Is July 31,2026 For Final Dividend.
Privi Speciality Chemicals set July 31, 2026, as record date for its final dividend. Shareholders as of this date are eligible for ₹10 per equity share for FY26.
May 11 2026 14:05:00
Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Change in Management
Privi Speciality Chemicals re-appointed Mr. Bhaktavatsala Rao Doppalapudi as Executive Director for a 3-year term, effective August 13, 2026. This re-appointment is subject to shareholder approval.
May 11 2026 14:05:00
Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Change in Directorate
Privi Speciality Chemicals re-appointed Mr. Bhaktavatsala Rao Doppalapudi as Executive Director (Whole-time Director) for a period of three years, from August 13, 2026, to August 12, 2029. This re-appointment is subject to approval by the shareholders at the upcoming 41st Annual General Meeting.
May 11 2026 14:05:00
Privi Speciality Chemicals Ltd - 530117 - Corporate Action-Board to consider Dividend
Privi Speciality Chemicals recommended a final dividend of ₹10 per equity share for FY26. The record date is July 31, 2026, with payment within 30 days of the August 07, 2026 AGM.
May 11 2026 14:05:00
Privi Speciality Chemicals Ltd - 530117 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Monday, May 11, 2026
Privi Speciality Chemicals board approved FY26 consolidated revenue of ₹2,563.69 cr (up 20.54% YoY) and net profit of ₹327.54 cr (up 75.16% YoY). Also recommended a final dividend of ₹10 per share, with the AGM scheduled for August 7, 2026.
May 11 2026 14:05:00
Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Privi Speciality Chemicals received a 'no objection' letter from BSE for its scheme of amalgamation. This regulatory approval is a key step for the proposed merger with Privi Fine Sciences and Privi Biotechnologies.
May 06 2026 18:05:00
Privi Speciality Chemicals Limited
Privi Speciality Chemicals Limited received a 'no objection' letter from BSE for its scheme of amalgamation with Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited. This is a crucial regulatory approval moving the merger forward, though other approvals are still pending.
May 06 2026 17:05:00
Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Privi Speciality Chemicals received a 'no objection' letter from NSE for its scheme of amalgamation. This is a key regulatory step towards integrating Privi Fine Sciences Pvt Ltd and Privi Biotechnologies Pvt Ltd into the company.
May 06 2026 12:05:00
Privi Speciality Chemicals Limited
Privi Speciality Chemicals received a 'no objection' observation letter from the National Stock Exchange of India on May 05, 2026, for its proposed scheme of amalgamation. This marks a significant regulatory milestone for the merger plan.
May 06 2026 12:05:00
Read More